A. Mitra

发表

Statistically significant association of the single nucleotide polymorphism (SNP) rs13181 (ERCC2) with predisposition to Squamous Cell Carcinomas of the Head and Neck (SCCHN) and Breast cancer in the north Indian population

A. Mitra, Neetu Singh, V. Garg, 2009, Journal of experimental & clinical cancer research : CR.

Regulation of cell cycle entry by PTEN in smooth muscle cell proliferation of human coronary artery bypass conduits

D. Agrawal, A. Mitra, Guanghong Jia, 2008, Journal of cellular and molecular medicine.

Feature II Pharmacogenomics-A New Approach to Drug Development

R. Sharma, A. Mitra, S. Rath, 2006 .

Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation

S. Raimondi, S. Meshinchi, T. Alonzo, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

FDA Approval Summary: Lenvatinib for Progressive, Radio-iodine–Refractory Differentiated Thyroid Cancer

K. He, P. Keegan, R. Pazdur, 2015, Clinical Cancer Research.

Angiotensin II and IGF-1 regulate connexin43 expression via ERK and p38 signaling pathways in vascular smooth muscle cells of coronary artery bypass conduits.

D. Agrawal, A. Mitra, Guanghong Jia, 2007, The Journal of surgical research.

Gene therapy of fibroproliferative vasculopathies: current ideas in molecular mechanisms and biomedical technology.

D. Agrawal, A. Mitra, 2006, Pharmacogenomics.

Profiling Bortezomib Resistance in Multiple Myeloma: Implications in Personalized Pharmacotherapy

J. Shaughnessy, B. Ness, A. Mitra, 2014 .

Genetic Variants in Cytosolic 5′-Nucleotidase II Are Associated with Its Expression and Cytarabine Sensitivity in HapMap Cell Lines and in Patients with Acute Myeloid Leukemia

J. Downing, S. Raimondi, D. Campana, 2011, Journal of Pharmacology and Experimental Therapeutics.

Genetic landscape of the people of India: a canvas for disease gene exploration

Ashutosh Kumar Singh, Amitabh Sharma, J. Kumar, 2008, Journal of Genetics.

Single-Cell Proteomics and Tumor RNAseq Identify Novel Pathways Associated With Clofazimine Sensitivity in PI- and IMiD- Resistant Myeloma, and Putative Stem-Like Cells

H. Kumar, Shaji K. Kumar, S. Rajkumar, 2022, Frontiers in Oncology.

Pathway-based pharmacogenomics of gemcitabine pharmacokinetics in patients with solid tumors.

R. Kratzke, A. Mitra, M. Kirstein, 2012, Pharmacogenomics.

Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein.

D. Agrawal, A. Mitra, Guanghong Jia, 2010, Experimental and molecular pathology.

The Indian Genome Variation database (IGVdb): a project overview

Debasis Dash, Ashutosh Kumar Singh, Arijit Mukhopadhyay, 2005, Human Genetics.

LIG1 polymorphisms: the Indian scenario

Ashutosh Kumar Singh, A. Mitra, S. Rath, 2014, Journal of Genetics.

Short palate, lung, and nasal epithelial clone 1 (SPLUNC1) level determines steroid-resistant airway inflammation in aging

A. Mitra, A. Jaiswal, A. Mishra, 2021, American journal of physiology. Lung cellular and molecular physiology.

NF-κB and CREB Are Required for Angiotensin II Type 1 Receptor Upregulation in Neurons

A. Mitra, I. Zucker, Karla K. V. Haack, 2013, PloS one.

Impact of genetic variation in FKBP5 on clinical response in pediatric acute myeloid leukemia patients: a pilot study

J. Downing, D. Campana, R. Ribeiro, 2011, Leukemia.

Single-Cell Transcriptomics Identifies Intra-Tumor Heterogeneity in Human Myeloma Cell Lines

B. Ness, A. Mitra, M. Linden, 2014 .

The Andrographolide Analogue 3A.1 Synergizes with Taxane Derivatives in Aggressive Metastatic Prostate Cancers by Upregulation of Heat Shock Proteins and Downregulation of MAT2A-Mediated Cell Migration and Invasion

A. Mitra, P. Opanasopit, R. Arnold, 2021, The Journal of Pharmacology and Experimental Therapeutics.

Integrating Pharmacogenomics Data-Driven Computational Drug Prediction with Single-Cell RNAseq to Demonstrate the Efficacy of a NAMPT Inhibitor against Aggressive, Taxane-Resistant, and Stem-like Cells in Lethal Prostate Cancer

P. Mistriotis, A. Mitra, Farshad Amiri, 2022, Cancers.

Molecular signatures of multiple myeloma progression through single cell RNA-Seq

Ying Li, Alexej Abyzov, Jin Jen, 2019, Blood Cancer Journal.

A gene expression signature distinguishes innate response and resistance to proteasome inhibitors in multiple myeloma

P. Sonneveld, Y. Li, J. Jen, 2017, Blood Cancer Journal.

Single-cell analysis of targeted transcriptome predicts drug sensitivity of single cells within human myeloma tumors

A. Abyzov, Y. Li, J. Jen, 2016, Leukemia.

Protective association exhibited by the single nucleotide polymorphism (SNP) rs1052133 in the gene human 8-oxoguanine DNA glycosylase (hOGG1) with the risk of squamous cell carcinomas of the head & neck (SCCHN) among north Indians

A. Mitra, V. Garg, Rashmi Chaturvedi, 2011, The Indian journal of medical research.

Identification of a de novo FOXP1 mutation and incidental discovery of inherited genetic variants contributing to a case of autism spectrum disorder and epilepsy

A. Mitra, B. V. Van Ness, T. Harding, 2019, Molecular genetics & genomic medicine.

Risk and Outcome of Breakthrough COVID-19 Infections in Vaccinated Patients With Cancer: Real-World Evidence From the National COVID Cohort Collaborative

U. Topaloglu, A. Mitra, T. Bergquist, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells.

Timothy K Starr, Molly Klein, Jerry Daniel, 2017, Gynecologic oncology.

Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin–Containing Chemotherapy

S. Raimondi, S. Meshinchi, T. Alonzo, 2013, Clinical Cancer Research.

A de novo splice site mutation in EHMT1 resulting in Kleefstra syndrome with pharmacogenomics screening and behavior therapy for regressive behaviors

A. Mitra, B. V. Van Ness, J. Dodge, 2016, Molecular genetics & genomic medicine.

Irg1/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation

A. Mitra, A. Jaiswal, A. Mishra, 2021, Mucosal immunology.

Analysis of single-nucleotide polymorphisms of PEO1 gene in 55 ethnic groups of India

Ashutosh Kumar Singh, A. Mitra, S. Rath, 2012 .

Irg1/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation

A. Mitra, A. Jaiswal, A. Mishra, 2021, Mucosal Immunology.

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells

A. Jakubowiak, A. Mitra, B. V. Van Ness, 2017, Oncotarget.

Integrating pharmacogenomics data-driven prediction with bulk and single-cell RNAseq to demonstrate the efficacy of an NAMPT inhibitor against aggressive, taxane-resistant, and stem-like cells in lethal prostate cancer

P. Mistriotis, A. Mitra, Farshad Amiri, 2022, bioRxiv.

Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer

G. Piazza, A. Mitra, R. C. Bird, 2021, Frontiers in Pharmacology.

Phenotypic and functional characterization of a bortezomib-resistant multiple myeloma cell line by flow and mass cytometry

A. Mitra, M. Linden, B. V. Van Ness, 2017, Leukemia & lymphoma.

Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.

S. Raimondi, D. Campana, E. Gamazon, 2013, Blood.

MYELOID NEOPLASIA Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identi ﬁ es polymorphisms associated with outcome in AML patients

S. Raimondi, D. Campana, E. Gamazon, 2013 .

RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients.

J. Downing, S. Raimondi, D. Campana, 2013, Pharmacogenomics.

Sequence and structure-based peptides as potent amyloid inhibitors: A review.

A. Mitra, N. Sarkar, 2020, Archives of biochemistry and biophysics.

"Vulnerable plaques"--ticking of the time bomb.

D. Agrawal, A. Mitra, A. Dhume, 2004, Canadian journal of physiology and pharmacology.

Temporal PTEN inactivation causes proliferation of saphenous vein smooth muscle cells of human CABG conduits

D. Agrawal, A. Mitra, Guanghong Jia, 2008, Journal of cellular and molecular medicine.

Cells, cytokines and cellular immunity in the pathogenesis of fibroproliferative vasculopathies.

D. Agrawal, A. Mitra, M. D. Del Core, 2005, Canadian journal of physiology and pharmacology.

Angiotensin II-induced upregulation of AT(1) receptor expression: sequential activation of NF-kappaB and Elk-1 in neurons.

Lie Gao, A. Mitra, Lie Gao, 2010, American journal of physiology. Cell physiology.

Molecular signatures of multiple myeloma progression through single cell RNA-Seq

A. Abyzov, Y. Li, J. Jen, 2019, Blood Cancer Journal.

Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial–Mesenchymal Transition

A. Mitra, R. C. Bird, R. Arnold, 2023, International journal of molecular sciences.

Sample average treatment effect on the treated analysis using counterfactual explanation identifies BMT and SARS-CoV-2 vaccination as protective risk factors associated with COVID-19 severity and survival in patients with multiple myeloma

U. Topaloglu, A. Mitra, T. Bergquist, 2022, medRxiv.

secDrug: a pipeline to discover novel drug combinations to kill drug-resistant multiple myeloma cells using a greedy set cover algorithm and single-cell multi-omics

H. Kumar, Shaji K. Kumar, A. Mitra, 2022, Blood Cancer Journal.

In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma

H. Kumar, Shaji K. Kumar, S. Rajkumar, 2020, Blood Cancer Journal.

Fine-Mapping of 18q21.1 Locus Identifies Single Nucleotide Polymorphisms Associated with Nonsyndromic Cleft Lip with or without Cleft Palate

C. Myers, Wen Wang, A. Mitra, 2016, Front. Genet..

Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma

J. Smadbeck, Shaji K. Kumar, A. Mitra, 2023, Blood cancer journal.

Association of CYP1A1 polymorphisms with breast cancer in North Indian women.

A. Mitra, Neetu Singh, V. Garg, 2007, Oncology research.

In stent restenosis: bane of the stent era

D. Agrawal, A. Mitra, A K Mitra, 2006, Journal of Clinical Pathology.

High-throughput drug screening identifies compounds and molecular strategies for targeting proteasome inhibitor-resistant multiple myeloma

C. Myers, B. Ness, T. Xia, 2014, Leukemia.

Association of polymorphisms in base excision repair genes with the risk of breast cancer: a case-control study in North Indian women.

Ashutosh Kumar Singh, A. Mitra, Neetu Singh, 2008, Oncology research.

Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial–mesenchymal Transition in Aggressive Variant Prostate Cancers

P. Mistriotis, A. Mitra, R. C. Bird, 2023, Cancer research communications.

Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein.

D. Agrawal, A. Mitra, Guanghong Jia, 2010, Experimental and molecular pathology.

TIVAN: tissue-specific cis-eQTL single nucleotide variant annotation and prediction

Li Chen, Xu Wang, Ye Wang, 2018, Bioinform..

Corrigendum to "Single cell sequencing reveals heterogeneity within ovarian cancer epithelium and cancer associated stromal cells" [Gyncol. Oncol. 144 (2017) 598-606].

K. Beckman, T. Starr, A. Mitra, 2018, Gynecologic oncology.

LIG1 polymorphisms: the Indian scenario

Ashutosh Kumar Singh, A. Mitra, S. Rath, 2014, Journal of Genetics.